Table of Contents Table of Contents
Previous Page  138 / 152 Next Page
Information
Show Menu
Previous Page 138 / 152 Next Page
Page Background

S134

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142

CD27+, CD45RA

, CD45RO+, PD1

, CD57

). Expansion rate of func-

tional T cells measured by ELISPOT IFN-gamma response was in

range 8

×

to 120

×

for individual CMV antigens. In the next step,

we shall determine cytolytic response against peptide pulsed or

virus infected targets and allogeneic reactivity of antiviral T cells

expanded in different media. The results will be shown at themeet-

ing.

The work was supported by grant NV15-34498A from AZV,

Czech Republic.

http://dx.doi.org/10.1016/j.jcv.2016.08.268

Abstract no: 145

Presentation at ESCV 2016: Poster 229

False-negative parvovirus B 19 serology in

pregnancy. Do we need PCR testing to detect or

exclude infection?

Barlinn Regine

1 ,

, H. Rollag

2

, L. Trogstad

1

,

P. Magnus

3

, K. Vainio

1

, S. Dudman

1

1

Division for Infection Control and Environmental

Health, Norwegian Institute of Public Health, Oslo,

Norway

2

Department of Medical Microbiology, Oslo

University Hospital, Norway

3

Division for Health Data and Digitalization,

Norwegian Institute of Public Health, Oslo, Norway

Aim:

The aim of the study was to investigate the parvovirus

B19 (B19) seroprevalence, new infection and vertical transmission

during pregnancy.

Material and methods:

Serum samples and questionnaires

from 1349 randomly selected pregnant women were included.

The samples were randomly selected from a Norwegian Mother

and Child Cohort Study (MoBa) that includes 114,000 children and

95,000 mothers recruited from all over Norway from 1999 to 2008.

Sera collected around week 17–18 (sample K1) were analysed for

B19 IgM and IgG using an enzyme linked immunosorbent assay

(Virion/Serion, Würzburg). All samples with IgG positive and IgM

negative results in K1 were classified as immune and no further

tests were done. IgG and IgM negative samples in K1 or samples

with an IgG equivocal result or IgM equivocal or positive result

were also analysed for B19 IgG and IgMon the sample taken at birth

(sample K2). Mothers with a seroconversion or with IgM equivocal

or positive results in K1 or K2 or with IgG equivocal results in K1

or K2 were tested with an in-house real-time B19 PCR. In addition,

corresponding umbilical cord blood samples were also analysed

with B19 PCR.

Results:

Mean age at delivery was 30.4 years and 40.2% was 29

year or younger. Mean gestational age at delivery was 39.7 weeks

and 47.1% was nulliparous. Of the 1349 women 61.7% were B19

IgG positive and IgM negative and 36% were both IgG and IgM neg-

ative. Among the initially seronegative women 6,8% seroconverted.

However, 2,3%had amore inconclusive serological profile including

either IgM or IgG equivocal results or IgM positive in K1and/or K2.

K1 and K2 samples from these 31 women with inconclusive sero-

logical profile and from the 33 women who seroconverted were

subjected to B19 PCR. Sixteen (51.6%) with inconclusive serological

profile and eighteen (54.6%) of those who seroconverted had virus

detectable by PCR either in K1 or K2 or both. Vertical infection was

seen in ten (15.6%) of these 64 children. Among the 16 women with

inconclusive serological profiles and a positive B19 PCR at week 17-

18, seven women were still seronegative also with an alternative

B19 IgG assay (Biotrin, Dublin) in the second sample taken at birth

(K2).

Conclusion:

In this cohort of pregnant women a high incidence

(2.5%) of viremic parvovirus B 19 infections was recorded, result-

ing in 26.5% of the children becoming infected. In almost half of

the women with an inconclusive serological profile combined with

positive PCR in K1, IgG was negative at birth (K2). In pregnancy

parvovirus B19 PCR is thus recommended since serology is often

not sufficient to detect or exclude infection.

http://dx.doi.org/10.1016/j.jcv.2016.08.269

Abstract no: 226

Presentation at ESCV 2016: Poster 230

Human cytomegalovirus (HCMV) genotyping in

congenital infection

F. Ferreira

, M.J. Chasqueira, P. Paixão

NOVA Medical School/Faculdade de Ciências

Médicas, Portugal

Background:

Human cytomegalovirus (HCMV) is the main con-

genital infection agent, affecting about 0.2–2.2% of all newborns.

This pathogen exhibits extensive genetic variabilitymainly in struc-

tural genes encoding envelope glycoproteins. The most relevant is

theHCMV glycoprotein B (gB), encoded by theUL55 gene, an impor-

tant target of the immune system of the human host. On the basis

of sequence variation of this gene, the virus can be classified at least

into 4 gB genotypes (types 1–4).

Objectives:

The aim of this study was to determine the

genotypes for UL55, present on samples from congenital and/or

perinatal infection cases in Portugal.

Study design:

HCMV gB genotyping was performed on 36

HCMV-positive urine samples and 20 amniotic fluid (LA) sam-

ples, collected from 2009 to 2016, by real time PCR. To confirm

the results, sequencing techniques (Sanger and Next-Generation

Sequencing) were performed.

Results:

35 urine samples could be assigned a gB genotype, in

29 was detected a single genotype (13 gB1; 7 gB2; 6 gB4; 3 gB3),

and in 6 mixed (>1) genotypes. Of the 19 LA samples, 17 had a sin-

gle genotype (5 gB1; 5 gB2; 5 gB3; 2 gB4), and in 2 were detected

mixed genotypes. No amplification was obtained in the other 2

samples (1 urine and 1 LA). Sequencing techniques did not confirm

the presence of mixed infections.

Conclusions:

gB1 seems to be the most common genotype in

congenital infection in Portugal, consistent with that described in

the literature. Also we corroborate the notion that all genotypes

can be involved in this type of infection. Mixed infections should

be subjected to further analysis, given the apparent contradiction

between PCR and sequencing results.

http://dx.doi.org/10.1016/j.jcv.2016.08.270

Abstract no: 36

Presentation at ESCV 2016: Poster 231

Practical experience in laboratory diagnosis of

congenital CMV infection over a period of 8

years in Slovakia

K. Kollárová

, D. Huˇcková

Medirex Inc, Canada

Primary and/or secondary cytomegalovirus infection of

pregnant women can lead to congenital (cCMV) or peri-/postnatal

infection. Serological screening of women before or during preg-

nancy for CMV specific antibodies is not usually performed in